Form 4: Zimmer Biomet Director Boosts Phantom Stock Holdings

Zimmer Biomet Director Michael J. Farrell acquired 415.144 phantom stock units, increasing his beneficial ownership to 17,775.682 units.

Summary

• Michael J. Farrell, a Director at Zimmer Biomet Holdings, Inc. (ZBH), acquired 415.144 phantom stock units.
• The transaction date for this acquisition was December 31, 2025.
• These phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The conversion or exercise price of the derivative security is 1-for-1, with a reference value of $90.33 per unit.
• Following this transaction, Michael J. Farrell beneficially owns a total of 17,775.682 phantom stock units.
• The units are to be settled in cash in a lump sum within sixty days after the cessation of the reporting person's service as a Director.
• The reported transaction includes 41.590 phantom stock units accrued on October 31, 2025, under the dividend reinvestment provision of the Deferred Compensation Plan.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The acquisition of additional phantom stock units by a director, particularly under a pre-planned Rule 10b5-1 program, generally indicates confidence in the company's long-term prospects, which is a positive signal for investors.

Positives

• A Director increasing their beneficial ownership, even through a deferred compensation plan, signals confidence in the company's future prospects.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned acquisition and reducing concerns about opportunistic trading.

Future Outlook

The phantom stock units are scheduled to be settled in cash in a lump sum within sixty days after Michael J. Farrell ceases his service as a Director.

Industry Context

Insider transactions, such as this acquisition of phantom stock units by a director, are closely watched by investors as they can provide insights into management's confidence in the company's future performance within the medical technology and orthopedic industry.

Corporate Governance

Stakeholder Impact

• Shareholders: The increase in a director's beneficial ownership can be interpreted as a positive signal of management's confidence in the company's future, potentially boosting investor sentiment.
• Employees: No direct impact mentioned.

Next Steps

• Settlement of phantom stock units in cash within sixty days after Michael J. Farrell's cessation of service as a Director.

Key Dates

Recommendation

The acquisition of additional phantom stock units by a director, particularly when executed under a Rule 10b5-1 plan, typically signals strong insider confidence in the company's future performance and valuation. This positive sentiment from a key insider suggests potential upside for the stock, warranting a 'buy' recommendation for investors looking for companies with strong internal conviction.

Keywords

Zimmer Biomet, ZBH, Form 4, Insider Transaction, Director, Phantom Stock Units, Beneficial Ownership, Deferred Compensation Plan, Rule 10b5-1